Market Place
Sourcing Support
All News #Library
Others
Biovica Appoints Theis Kipling as New CEO
07 Apr 2026 //
PHARMIWEB
Biovica International AB: Q3 Interim Report, Nov 2025–Jan 2026
18 Mar 2026 //
ACCESSWIRE
Biovica International AB Nominates Committee For AGM 2026
09 Mar 2026 //
ACCESSWIRE
Biovica Plans CEO Succession; Rylander To Step Down In 2026
05 Mar 2026 //
PHARMIWEB
Biovica International AB - Q2 Interim report Aug - Oct 2025
18 Dec 2025 //
PHARMIWEB
Biovica Inks Client Bill Deal With Top U.S. Cancer Center
15 Dec 2025 //
PHARMIWEB
Biovica`s Q1 Interim Report: May-July 2025
11 Sep 2025 //
PHARMAWEB
Annual General Meeting Notice for Biovica International AB
22 Aug 2025 //
PHARMAWEB
Biovica Conducts Directed Share Issue Worth MSEK 42.2
13 Aug 2025 //
ACCESSWIRE
Biovica International AB - Annual Report for the Financial Year
27 Jun 2025 //
ACCESSWIRE
Biovica Secures Three New Work Orders Worth 2.5 MSEK Value
10 Jun 2025 //
ACCESSWIRE
Biovica Sets Financial Targets After Partnerships and Progress
10 Jun 2025 //
ACCESSWIRE
Biovica partners Tempus to expand DiviTum(R) TKa Reach
13 May 2025 //
ACCESSWIRE
Biovica Signs Agreement with American Health Giant
03 Dec 2024 //
ACCESSWIRE
Biovica signs commercial agreement with MediNcrease for DiviTum TKa in US
19 May 2023 //
PHARMABIZ
Announcement from Biovica International AB`s annual general meeting
31 Aug 2022 //
ACCESSWIRE
Biovica Announces Start of TK IMPACT Trial at Washington University of St Louis
24 Nov 2021 //
BIOSPACE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.